Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04641039
Other study ID # 101/2020
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 1, 2020
Est. completion date April 28, 2025

Study information

Verified date May 2022
Source University of Valencia
Contact Vicente Vanaclocha, MDPhD
Phone + 34 963 13 18 00
Email vivava@uv.es; vvanaclo@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To implant a complete lumbar disc prosthesis removal of the anterior portion of the annulus fibrosus is required. As the anterior portion of the annulus limits the movement in extension and axial rotation, we would like to know how much increase these two disc movements and also the effect on the postoperative prevertebral scar on the reduction of these abnormal movement ranges. We also aim to see if repairing intraoperatively the anterior portion of the annulus has any advantage in the final result achieved.


Description:

To implant a complete lumbar disc prosthesis removal of the anterior portion of the annulus fibrosus is required. It is known that the anterior portion of the annulus limits the movement in extension and axial rotation, so removal of this section of the annulus fibrosus will increase the range of movement in extension and axial rotation. As far as the investigators know, this increase in movement ranges has not been measured objectively in alive patients. Also the investigators would like to know if the postoperative prevertebral scar reduces an to what extent these abnormal movement ranges. This could help the investigators to decide when patients should be allowed to regain normal activities and specially, when the patients should be allowed to start working again. The investigators also aim to see if repairing intraoperatively the anterior portion of the annulus has any advantage in the final result achieved, and thus represents an improvement or not in the care of these patients


Recruitment information / eligibility

Status Recruiting
Enrollment 24
Est. completion date April 28, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Minimum age of 18 years and maximum of 50 years, given that above that age there is usually degenerative pathology of the lumbar joint facets, which can confuse the symptoms and make it difficult to interpret the results. - Pathology compatible with chronic low back pain accompanied or not by radiculopathy originating in one or a maximum of two degenerated intervertebral discs and without signs of degeneration / osteoarthritis of the lumbar joint facets. - The type of lumbar pain must be discogenic, that is, worsen in flexion and not in extension, and in loading, as well as having a truncal distribution with possible anterior radiation towards the English or genital region. - Radiological confirmation by lumbar MRI study of lumbar discopathy of one or a maximum of two lumbar levels. - Absence in simple radiology studies of signs of vertebral instability or listhesis of the levels to be treated. - Absence of response for 6 weeks to conservative, non-surgical treatment, or presence of progressive symptoms. The treatment would also be carried out despite the absence of this study and the existence of the study does not condition in any way the treatment of the patients - Not having undergone any prior treatment of the type of microdiscectomy, laminectomy or lumbar arthrodesis, although these have been carried out at different levels than those involved on this occasion - Ability of the patient to comply with the proposed monitoring program - Patient's ability to follow the postoperative care program - Granting of informed consent Exclusion Criteria: - Signs of arthropathy of the lumbar joint facets, osteoporosis, previous interventions on the lumbar spine - Deformity or instability of the lumbar spine - Lumbar canal stenosis - Previous intervention on lumbar spine - Previous lumbar spinal fracture - Mobile spondylolisthesis> 2 mm in translation and / or more than 11 ° angular difference with respect to the adjacent level on neutral vertical or flexion-extension radiographs - Severe osteoporosis - Spinal metastasis - Metabolic bone disease that could interfere with the implant or the surgical procedure - Rheumatoid arthritis, lupus, or other autoimmune disease that affects the musculoskeletal system - Other conditions or anatomical alterations that make the treatment of the anterior approach to the lumbar spine unfeasible - Known allergy to stainless steel, titanium or their alloys - Fixed or permanent neurological deficit - Active systemic infection at any time or ongoing preventive treatment for it, infection in the surgical site, HIV or hepatitis C - Abusive drug or alcohol use - Uncontrolled seizure disorder - Psychiatric illness that could interfere with your participation in the study - Participation in a current research study or in the 3 months prior to surgery - History of malignancy or current malignancy (except non-melanoma skin cancer), unless the patient has been treated for curative purposes and no clinical signs or symptoms have been observed for at least 5 years - Obesity (Body Mass Index or BMI> 35)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Anterior lumbar disc annulus removal versus replacement
Owestry scale, SF12, Facet joint arthritis measured with Pathria scale, discal degeneration measured with Modic and Phirrmann scales

Locations

Country Name City State
Spain Hospital General Universitario de Valencia Valencia

Sponsors (1)

Lead Sponsor Collaborator
University of Valencia

Country where clinical trial is conducted

Spain, 

References & Publications (3)

Auerbach JD, Jones KJ, Milby AH, Anakwenze OA, Balderston RA. Segmental contribution toward total lumbar range of motion in disc replacement and fusions: a comparison of operative and adjacent levels. Spine (Phila Pa 1976). 2009 Nov 1;34(23):2510-7. doi: 10.1097/BRS.0b013e3181af2622. — View Citation

Frelinghuysen P, Huang RC, Girardi FP, Cammisa FP Jr. Lumbar total disc replacement part I: rationale, biomechanics, and implant types. Orthop Clin North Am. 2005 Jul;36(3):293-9. doi: 10.1016/j.ocl.2005.02.014. — View Citation

Huang YJ, Zhao SJ, Zhang Q, Nong LM, Xu NW. Comparison of lumbar pedicular dynamic stabilisation systems versus fusion for the treatment of lumbar degenerative disc disease: A meta-analysis. Acta Orthop Belg. 2017 Mar;83(1):180-193. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Range of spinal segment movement after lumbar disc prosthesis insertion in L4-L5 lumbar disc The investigators will analyze preoperatively and postoperatively at 3, 6 and 12 months the range of movement of the L4-L5 lumbar disc after insertion of a complete lumbar disc prosthesis One year
See also
  Status Clinical Trial Phase
Completed NCT01941563 - A Study of SI-6603 in Patients With Lumbar Disc Herniation Phase 3
Completed NCT04061759 - Physiotherapy in Lumbar Disc Pathologies N/A
Recruiting NCT04727385 - Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease N/A
Completed NCT04587401 - The Effects of Anesthesia on Cerebral Perfusion in Patients With High Blood Pressure N/A
Not yet recruiting NCT06034041 - The Effect of Mediclore as an Anti-adhesion Agent and Safety in Full-endoscopic Spine Surgery: a Preliminary Study Phase 4
Recruiting NCT04134975 - Evaluation of the Contribution of Intraoperative Scans Coupled With the Navigation for the Precision of the Positioning of the Pedicle Screws During a Lumbar Spine Surgery: a Prospective Randomised Study N/A
Recruiting NCT05146583 - Injection of Autologous Bone Marrow Aspirate in Patients With Degenerative Disc Disease.
Completed NCT04301232 - Fast-Track Eligibility and Hospital Discharge for Outpatient Lumbar Discectomy
Recruiting NCT06154005 - OsteoAdapt SP Advanced Bone Graft Feasibility Study - Transforaminal Interbody Lumbar Fusion Phase 1/Phase 2
Completed NCT03977961 - The Six-Minute Walking Test (6MWT) as a Measure of Functional Impairment in Lumbar Degenerate Disc Disease.
Enrolling by invitation NCT05444751 - GA + ESP vs. SA + ESP in Lumbar Decompression Surgeries Phase 3
Completed NCT02700451 - Post-op Acetaminophen vs NSAID Use on Lumbar Spinal Fusion Outcomes N/A
Completed NCT02421601 - A Study of SI-6603 in Patients With Lumbar Disc Herniation Phase 3
Active, not recruiting NCT03733626 - Clinical Outcomes Associated With the Use of ViviGen® for the Treatment of Lumbar Degenerative Disc Disease N/A
Recruiting NCT04042844 - A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD) Phase 2
Recruiting NCT06462729 - LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF) Phase 1/Phase 2
Completed NCT05345249 - Erector Spinae Plane Block as Pain Management After Lumbar Fusion Surgery Phase 4
Active, not recruiting NCT03060434 - Pentoxifylline and Lumbar Radiculopathy Phase 4
Withdrawn NCT02852187 - Single Center Study Comparing MOBIS II ST vs MOBIS PEEK N/A
Completed NCT04062942 - The Six-Minute Walking Test (6WT) and Timed-Up-and-Go (TUG) Test as Measures of Objective Functional Impairment in Patients Undergoing Interlaminar or Transforaminal Epidural Steroid Injection for Lumbar Degenerative Disc Disease (DDD)